CLINICAL_TRIALS
trial_result
· 2025-10-24
Clinical Trial Update: High Dose Risankizumab for Psoriasis [Phase 2]
Summary
A Phase 2 trial evaluating high-dose risankizumab for psoriasis has completed, with results posted on 2025-10-24.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Oregon Medical Research Center | Conditions: Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2025-10-24